Pharmaceutical laboratories utilize these materials for impurity profiling, method validation, and rigorous quality control during the synthesis of antibody-drug conjugates. By providing high-quality reference standards and intermediates, these compounds enable researchers to characterize the stability, drug-to-antibody ratio, and release mechanisms of their therapeutic candidates. These materials are fundamental for assessing how linker-payload systems perform, ensuring precise and effective targeted delivery while supporting the structural analysis required for the development of both novel and established antibody-based drug platforms in preclinical and clinical environments.